| 2007 |
Homozygous single-nucleotide deletion (c.144delC) in AURKC results in premature translation termination, producing a truncated protein lacking the kinase domain, and causes male infertility by producing large-headed, multiflagellar, polyploid (tetraploid) spermatozoa due to failed meiosis. |
Genome-wide microsatellite scan, sequencing of AURKC coding sequence, flow cytometry for ploidy assessment |
Nature genetics |
High |
17435757
|
| 1998 |
AURKC (STK13) encodes a serine/threonine protein kinase related to Drosophila Aurora and budding yeast Ipl1, mapping to human chromosome 19q13.3-ter; its cDNA was isolated from testis mRNA indicating testis-predominant expression. |
cDNA library screening, 5' RACE, somatic cell hybrid PCR, radiation hybrid mapping, FISH |
Genomics |
Medium |
9799611
|
| 2018 |
In mouse oocyte meiosis, AURKC is the predominant catalytic subunit of the chromosomal passenger complex (CPC); in the absence of AURKC, AURKA aberrantly localizes to chromosomes in a CPC-dependent manner, and AURKB negatively regulates AURKC activity to prevent aneuploidy. This inter-kinase regulation controls spindle length and chromosome segregation fidelity during meiosis I. |
Oocyte-specific single and double knockout mice (Aurkb and Aurkc KO), immunofluorescence localization, fecundity assays |
Current biology : CB |
High |
30415701
|
| 2016 |
Three macrozoospermia-associated AURKC mutations have distinct functional consequences: p.L49Wfs22 (c.144delC) is a loss-of-function allele that disrupts CPC localization; p.C229Y is a hypomorphic allele that cannot fully support meiotic cell-cycle progression; p.Y248* fails to localize and function within the CPC but retains cytoplasmic catalytic activity. All three cause metaphase chromosome misalignment and polyploidy via failure of AURKC-CPC function. |
Expression of mutant AURKC alleles in Aurkc-/- mouse oocytes, immunofluorescence for CPC localization, flow cytometry for ploidy, in vitro kinase assay |
Human molecular genetics |
High |
27106102
|
| 2017 |
Haspin inhibition in late prometaphase I causes loss of interchromatid axis-localized AURKC, acceleration of meiosis I, and bypass of the spindle assembly checkpoint (SAC). In contrast, oocytes from Aurkc-/- mice (where AURKB is the sole CPC kinase) show no change in MI timing or MAD2 localization upon haspin inhibition, demonstrating that interchromatid axis-localized AURKB is not required for SAC activation and revealing a functional difference between AURKB and AURKC within the CPC. |
Haspin kinase inhibition in wild-type and Aurkc-/- mouse oocytes, immunofluorescence for AURKC, AURKB, MAD2 localization, live imaging for MI timing |
Molecular biology of the cell |
High |
28659416
|
| 2011 |
Aberrantly expressed AURKC localizes to centromeric regions of mitotic chromosomes, decreases AURKB protein levels, and its kinase activity is required for increased cell proliferation, transformation, and migration. AURKC expression is transcriptionally repressed by PLZF, which is recruited to the AURKC promoter. |
AURKC-GFP overexpression in epithelial/cancer cell lines, kinase-dead mutant analysis, colony formation and migration assays, ChIP for PLZF at AURKC promoter, immunofluorescence |
The Journal of pathology |
Medium |
21710690
|
| 2011 |
A splice-site mutation (c.436-2A>G) in AURKC causes skipping of exon 5, producing a truncated transcript, and combined with heterozygous c.144delC causes compound heterozygous AURKC loss of function leading to macrozoospermia. |
AURKC gene sequencing, RT-PCR of patient leukocyte transcripts demonstrating exon skipping |
Molecular human reproduction |
Medium |
21733974
|
| 2017 |
AURKC physically interacts with IκBα and phosphorylates IκBα at Ser32, thereby activating NF-κB signaling in breast cancer cells; a small-molecule inhibitor (AKCI) that blocks the AURKC-IκBα protein-protein interaction induces G2/M arrest and inhibits migration, invasion, and tumor growth. |
Translocation-based cellular binding assay, identification of IκBα as AURKC binding partner, phosphorylation assay, small-molecule inhibitor (AKCI) treatment, NF-κB reporter assays, colony formation, xenograft tumor model |
Oncotarget |
Medium |
29050234
|
| 2015 |
Promoter CpG island hypomethylation is a key positive regulator of AURKC expression; demethylation with 5-aza-dC (but not the HDAC inhibitor TSA) elevates AURKC expression in cancer cell lines, and testis shows marked promoter hypomethylation consistent with high expression. PLZF-mediated repression only partially offsets AURKC expression even after demethylation, indicating that CpG methylation is the dominant regulatory mechanism. |
5-aza-dC and TSA pharmacological treatment, quantitative methylation analysis, RT-qPCR, TCGA dataset cross-validation, PLZF overexpression experiments |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine |
Medium |
25990457
|
| 2025 |
AURKC interacts with and upregulates ERp57 protein in clear cell renal cell carcinoma; AURKC knockdown reduces CyclinD1, PCNA, and ERp57 levels and inhibits proliferation in vitro and tumor growth in vivo, while AURKC overexpression increases ERp57 and proliferation. |
Co-immunoprecipitation and colocalization (AURKC-ERp57 interaction), shRNA knockdown and overexpression in ccRCC cell lines, xenograft tumor mouse model, western blot for CyclinD1/PCNA/ERp57 |
Journal of Cancer |
Low |
39895780
|